Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(S)-2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine

EU orphan designation number: EU/3/07/513   
Active ingredient: (S)-2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
Indication: Treatment of tuberculosis
Sponsor: Dr Ulrich Granzer
Forst-Kasten-Strasse 9B, D-82152 Krailling, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/12/2007 Centralised Orphan - Designation EMEA/OD/074/07 (2007)6024 of 29/11/2007